✦ LIBER ✦

Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity

✍ Scribed by Aisaku YAMAMOTO; Hideaki WATANABE; Hirohiko SUEKI; Takako NAKANISHI; Hajime YASUHARA; Masafumi IIJIMA

Book ID: 108576282
Publisher: John Wiley and Sons
Year: 2007
Tongue: French
Weight: 749 KB
Volume: 34
Category: Article
ISSN: 0385-2407
DOI: 10.1111/j.1346-8138.2007.00304.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PTK787/ZK 222584, a small molecule tyros

PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia

✍ Francis J. Giles; Alan F. List; Michael Carroll; Jorge E. Cortes; Joyce Valickas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

PTK787/ZK222584, a tyrosine kinase inhib

PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo

✍ Markus Rudin; Paul M. J. McSheehy; Peter R. Allegrini; Martin Rausch; Diana Baum 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

## Abstract Assessment of tumour vascularity may characterize malignancy as well as predict responsiveness to anti‐angiogenic therapy. Non‐invasive measurement of tumour perfusion and blood vessel permeability assessed as the transfer constant, __K__^trans^, can be provided by dynamic contrast‐enha

Phase I pharmacokinetic study of the vas

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

✍ David A. Reardon; Merrill J. Egorin; Annick Desjardins; James J. Vredenburgh; Ja 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views